Hongzhang He
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2018First federal award
$3.7MFederal grants as PI8 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
8 awards · $3.7M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| May 12, 2026 | NIH | SBIR Phase II Magnetic Lipid Nanoprobe Platform for Rapid, Highly-Efficient, and Cost-Effective Isolation of Extracellular Vesicles from Non-Invasive Bodily Fluids | $1.1M | CAPTIS DIAGNOSTICS |
| Mar 11, 2025 | NIH | SBIR Phase II Magnetic Lipid Nanoprobe Platform for Rapid, Highly-Efficient, and Cost-Effective Isolation of Extracellular Vesicles from Non-Invasive Bodily Fluids | $1.1M | CAPTIS DIAGNOSTICS |
| Jun 1, 2023 | NIH | SBIR Phase I Non-invasive detection of tumor NTRK gene fusions via rapid, efficient and low-cost extracellular vesicle isolation method | $400K | CAPTIS DIAGNOSTICS |
| Aug 6, 2019 | NIH | SBIR Phase I Develop a rapid, efficient and low cost extracellular vesicles isolation method toward non-invasive non-small cell lung cancer molecular analysis | $2K | CAPTIS DIAGNOSTICS |
| Apr 16, 2019 | NIH | SBIR Phase I Develop a rapid, efficient and low cost extracellular vesicles isolation method toward non-invasive non-small cell lung cancer molecular analysis | $55K | CAPTIS DIAGNOSTICS |
| Apr 4, 2019 | NIH | SBIR Phase I An ultrasensitive virus identification method for acute respiratory virus infections using carbon nanotube arrays-integrated microdevice | $300K | CAPTIS DIAGNOSTICS |
| Aug 1, 2018 | NIH | SBIR Phase I Develop a rapid, efficient and low cost extracellular vesicles isolation method toward non-invasive non-small cell lung cancer molecular analysis | $357K | CAPTIS DIAGNOSTICS |
| — | NIH | SBIR Phase I CAPTIS DIAGNOSTICS - SBIR CONCEPT AWARD - DEVELOPMENT OF NON-INVASIVE ASSAY FOR MOLECULAR CHARACTERIZATION OF PEDIATRIC LOW-GRADE GLIOMA | $355K | CAPTIS DIAGNOSTICS |
Peer ranks
Federal funding#485
Awards as PI#216
Patents#505
Companies
- CAPTIS DIAGNOSTICSLinked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.